![Jason Gross](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Gross
Chief Tech/Sci/R&D Officer at
HLS THERAPEUTICS INC.
Net worth: 148 106 $ as of 31/07/2026
Profile
Jason A. Gross is currently Vice President-Scientific Affairs at HLS Therapeutics, Inc., a position held since 2014.
Former roles include Vice President-Scientific & Medical Affairs at Cipher Pharmaceuticals, Inc. from 2012 to 2013, Vice President at Lumira Capital Investment Management, Inc., VP-Scientific & Medical Affairs at IVAX Pharmaceuticals, Inc., VP-Regulatory Affairs & Quality Assurance at Drugabuse Sciences, Inc., and Vice President-Scientific Affairs at HLS Therapeutics, Inc. Education includes a doctorate from the University of Arizona.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 26/06/2026 | 49,700 ( 0.16% ) | 148 106 $ | 31/07/2026 |
Jason Gross active positions
| Companies | Position | Start |
|---|---|---|
| HLS THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/06/2014 |
Former positions of Jason Gross
| Companies | Position | End |
|---|---|---|
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Private Equity Investor | 31/03/2006 |
HLS Therapeutics, Inc. /Old/
 HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides specialty pharmaceutical products | Corporate Officer/Principal | - |
IVAX Pharmaceuticals, Inc.
 IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Chief Tech/Sci/R&D Officer | - |
Drugabuse Sciences, Inc. | General Counsel | - |
| CIPHER PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | - |
Training of Jason Gross
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
25
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Cipher Pharmaceuticals, Inc.
 Cipher Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Provides laboratory testing and medical imaging services | Health Technology |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVAX Pharmaceuticals, Inc.
IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Drugabuse Sciences, Inc. | |
HLS Therapeutics, Inc. /Old/
HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides specialty pharmaceutical products | Health Technology |
HLS Therapeutics, Inc.
 HLS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Jason Gross
